Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00722930
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 2)

Lymphoma, Follicular (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3